or Try an Advanced Search...

    Technical Analysis for FBRX - Forte Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 16.50 12.86% 1.88
    FBRX closed up 12.86 percent on Wednesday, January 15, 2025, on 10 percent of normal volume. It ran into resistance at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Flat Down
    Historical FBRX trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Resistance Bearish 12.86%
    MACD Bearish Centerline Cross Bearish 12.86%
    Lower Bollinger Band Walk Weakness 12.86%
    Wide Bands Range Expansion 12.86%
    Below Lower BB Weakness 12.86%
    Down 3 Days in a Row Weakness 12.86%
    Older End-of-Day Signals for FBRX ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 10 hours ago
    60 Minute Opening Range Breakout about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Rose Above 50 DMA about 10 hours ago
    50 DMA Resistance about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    FBRX Chart by TradingView

    Profile

    Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes

    Is FBRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Dec 13 Forte Biosciences files for secondary offering of common stock
    Nov 25 Forte Biosciences to Host R&D Day December 3, 2024
    Nov 20 Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
    Nov 20 Forte Biosciences announces oversubscribed $53 million private placement
    Nov 20 Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
    Nov 15 Forte Biosciences GAAP EPS of -$4.54
    Nov 14 Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
    Aug 26 Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
    Aug 14 Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
    See more FBRX news...

    Comments

    Indicators

    Indicator Value
    52 Week High 28.68
    52 Week Low 4.11
    Average Volume 690,897
    200-Day Moving Average 13.07
    50-Day Moving Average 16.58
    20-Day Moving Average 19.99
    10-Day Moving Average 20.02
    Average True Range 2.92
    RSI (14) 43.18
    ADX 31.82
    +DI 19.38
    -DI 23.86
    Chandelier Exit (Long, 3 ATRs) 17.22
    Chandelier Exit (Short, 3 ATRs) 22.57
    Upper Bollinger Bands 25.34
    Lower Bollinger Band 14.64
    Percent B (%b) 0.17
    BandWidth 53.56
    MACD Line -0.25
    MACD Signal Line 0.86
    MACD Histogram -1.1146
    Fundamentals Value
    Market Cap 599.53 Million
    Num Shares 36.3 Million
    EPS -1.20
    Price-to-Earnings (P/E) Ratio -13.75
    Price-to-Sales 0.00
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.69
    Resistance 3 (R3) 20.66 19.23 19.99
    Resistance 2 (R2) 19.23 18.17 19.25 19.76
    Resistance 1 (R1) 17.87 17.51 18.55 17.90 19.53
    Pivot Point 16.44 16.44 16.78 16.45 16.44
    Support 1 (S1) 15.07 15.37 15.76 15.10 13.47
    Support 2 (S2) 13.64 14.71 13.66 13.24
    Support 3 (S3) 12.28 13.64 13.01
    Support 4 (S4) 12.31